Share on LinkedInShare on LinkedIn

ARTICLE · 30 MAY 2022

Third Post-Arthrex Grant Of Director Review Issued

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

On March 3, 2022, Andrew Hirshfeld, the Commissioner for Patents and acting Director of the USPTO, issued the third post-Arthrex grant of Director Review for two separate Final Written Decisions issued by the PTAB...

United StatesIntellectual Property

On March 3, 2022, Andrew Hirshfeld, the Commissioner for Patents and acting Director of the USPTO, issued the third post-Arthrex grant of Director Review for two separate Final Written Decisions issued by the PTAB based on a Federal Circuit claim construction in a related case that ran counter to the PTAB's construction.

The '635 Patent pertains to a unified system of programming communication and its challenged claims relate to the methods of controlling the decryption of programming at a subscriber station or a receiver station. On September 19, 2017 and February 15, 2018, Apple Inc. filed two separate petitions to institute a review of claims of the '635 Patent. See Apple Inc. v. Personalized Media Communications, LLC, IPR2016-01520 and IPR2016-00754.. Trial was instituted, and in the Final Written Decisions, the PTAB found that twelve of the challenged claims Patent were unpatentable as obvious or anticipated. See id.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from